Moderna asks for approval of covid -booster while Sweden bans it for under 30s | Covid 19
Drug manufacturer Moderna is asking Health Canada to approve the administration of its COVID-19 booster shot, given reduced immunity from the first two doses after several months.
Right now, in Quebec, the third dose can be given to those living in long-term care facilities (CHSLD), private nursing homes (RPA) and family-type or intermediate housing (RI-RTF) and people with compromised immune systems who are undergoing dialysis.
Health Canada wrote on Twitter that it “conducts a thorough, independent and evidence-based review of [Moderna’s] submission.”
Some advocates, including the World Health Organization, have called for a slowdown in boosters so that people in poorer countries can access the vaccine.
On the other hand, the governments of Sweden and Denmark currently stopped the administration of Moderna – Sverige for the 30 and under and Denmark for those under 18. The cause is increased but rare incidents of myocarditis and pericarditis among some young people, which involves an inflammation in the heart and its mucous membranes.
“The connection is particularly clear when it comes to Moderna’s vaccine Spikevax, especially after the second dose,” said the Swedish health authority and also emphasized that the risk was small.
Modern responded to Reuters that “these are usually mild cases and individuals tend to recover shortly after standard treatment and rest. The risk of myocarditis increases significantly for those affected by COVID-19, and vaccination is the best way to protect against this. . “